Mayville Engineering Company, Inc.
NYSE:MECManufacturing - Metal Fabrication
+$1.19 today
- Market cap
- $333.55M
- Beta
- 1.29
- P/E (TTM)
- -43.5
- EPS (TTM)
- -$0.80
Volume 0.58M
Average 0.37M
MEC Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Mayville Engineering Company, Inc.NYSE: MEC
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables growth accelerates
Q1 FY2026 accounts receivables of $10.6M (cash outflow) rose 29.8% year over year, ahead of the -71.8% change in trailing-twelve-month accounts receivables.
Context
- Accounts receivables amounted to 1.1% of revenue in FY2025, down 0.3 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +29.8% holds above the trailing-twelve-month pace of -71.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 6.04M USD
- Year-over-year change
- -25.4%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.04M | -25.4% |
| FY2024 | 2024-12-31 | 8.1M | +4.0% |
| FY2023 | 2023-12-31 | 7.79M | +411.9% |
| FY2022 | 2022-12-31 | (2.5M) | +80.3% |
| FY2021 | 2021-12-31 | (12.67M) | — |
Accounts Receivables vs competitors
How MEC compares with its peers on the latest reported figures
- MEC's LTM Mar 2026 accounts receivables of $3.61M is the 7th largest of the 10 companies compared; the peer median is $727.39K.
- Its year-over-year change of -71.8% is the 6th highest of 10, against a peer median of -53.8%.
- Accounts receivables amounts to 0.6% of revenue for MEC, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $33.69M | -45.4% | — | 1.1% | |
| LTM Mar 2026 | $14.54M | +70.0% | — | 2.1% | |
| LTM Mar 2026 | $10.3M | -53.8% | -37.0% | 0.5% | |
| LTM Mar 2026 | $6.68M | -284.5% | — | 1.8% | |
| LTM Mar 2026 | $6.14M | -42.1% | +96.0% | 1.8% | |
| LTM Mar 2026 | $3.93M | +74.2% | — | 6.2% | |
| LTM Mar 2026 | $3.61M | -71.8% | — | 0.6% | |
| LTM Mar 2026 | $3.28M | -78.6% | — | 0.9% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $727.39K | -230.0% | — | 0.4% |
| LTM Mar 2026 | $200K | -132.1% | — | 0.1% | |
| Peer median (excluding MEC) | $727.39K | -53.8% | +29.5% | 1.1% | |
Competitors are the stored peer set for MEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (7.45M) | 18.73M | 7.84M | 25.97M | (8.11M) |
| Depreciation & Amortization | 31.78M | 29.31M | 35.08M | 37.59M | 31.57M |
| Deferred Income Tax | 0 | 0 | 0 | 4.23M | (5.53M) |
| Stock-Based Compensation | 4.96M | 3.76M | 4.49M | 5.19M | 3.28M |
| Change in Working Capital | (28.59M) | 4.49M | 5.24M | 15.37M | (411K) |
| Accounts Receivables | (12.67M) | (2.5M) | 7.79M | 8.1M | 6.04M |
| Inventory | (27.9M) | (1.63M) | 16M | 13.25M | 77K |
| Accounts Payables | 11.84M | 9.36M | (9.44M) | (7.99M) | 8.36M |
| Other Working Capital | 144K | (747K) | (9.11M) | 2.02M | (14.89M) |
| Other Non-Cash Items | 13.75M | (3.86M) | (12.29M) | 1.47M | 17.77M |
| Operating Cash Flow | 14.46M | 52.43M | 40.36M | 89.81M | 38.56M |
| Capital Expenditures | (39.31M) | (58.61M) | (16.6M) | (12.1M) | (11.65M) |
| Acquisitions (Net) | 0 | 0 | (88.59M) | 0 | (139.95M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 5.35M | 7.94M | 1.06M | 386K | 72K |
| Investing Cash Flow | (33.96M) | (50.67M) | (104.13M) | (11.71M) | (151.53M) |
| Debt Repayment | 21.54M | 3.2M | 68.18M | (69.18M) | 121.27M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.15M) | (4.95M) | (2.66M) | (5.9M) | (4.61M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 113K | 0 | (1.21M) | (3.48M) | (2.4M) |
| Financing Cash Flow | 19.5M | (1.75M) | 64.31M | (78.56M) | 114.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (3K) | 9K | 545K | (466K) | 1.3M |
| Free Cash Flow | (24.85M) | (6.18M) | 23.77M | 77.71M | 26.91M |
Mayville Engineering Company, Inc.
NYSE:MEC
Intrinsic Alpha fair value
Locked
Current Price
$13.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.